This company listing is no longer active
Resumen de acción 3TP0
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men’s and women’s health.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 2 riesgos adicionales
Competidores de Acerus Pharmaceuticals Corporation
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.20 |
| 52 Week High | US$7.90 |
| 52 Week Low | US$0.14 |
| Beta | 0.99 |
| 1 Month Change | 0% |
| 3 Month Change | -77.36% |
| 1 Year Change | -95.31% |
| 3 Year Change | -91.05% |
| 5 Year Change | -99.37% |
| Change since IPO | -99.74% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| 3TP0 | DE Pharmaceuticals | Mercado DE | |
|---|---|---|---|
| 7D | 0% | -0.7% | -0.5% |
| 1Y | -95.3% | -20.1% | 5.2% |
Rentabilidad vs. Industria: 3TP0 underperformed the German Pharmaceuticals industry which returned 3.3% over the past year.
Rentabilidad vs. Mercado: 3TP0 underperformed the German Market which returned -2.5% over the past year.
Volatilidad de los precios
| 3TP0 volatility | |
|---|---|
| 3TP0 Average Weekly Movement | 34.8% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.5% |
Precio estable de las acciones: 3TP0's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: 3TP0's weekly volatility (35%) has been stable over the past year, but is still higher than 75% of German stocks.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2008 | 14 | Ed Gudaitis | www.aceruspharma.com |
Resumen de fundamentos de Acerus Pharmaceuticals Corporation
| Estadísticas fundamentales de 3TP0 | |
|---|---|
| Capitalización bursátil | €2.62m |
| Beneficios(TTM) | -€26.54m |
| Ingresos (TTM) | €2.87m |
0.6x
Ratio precio-ventas (PS)-0.1x
Ratio precio-beneficio (PE)¿Está 3TP0 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 3TP0 | |
|---|---|
| Ingresos | US$3.04m |
| Coste de los ingresos | US$1.33m |
| Beneficio bruto | US$1.71m |
| Otros gastos | US$29.79m |
| Beneficios | -US$28.08m |
Últimos beneficios comunicados
Sep 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -3.64 |
| Margen bruto | 56.32% |
| Margen de beneficio neto | -924.33% |
| Ratio deuda/patrimonio | -329.8% |
¿Cómo se ha desempeñado 3TP0 a largo plazo?
Ver rendimiento histórico y comparativa